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Metastatic propensityRecent preclinical studies have shown that interstitial fluid pressure (IFP) within tumors can be hetero-
geneous Andersen et al. (2019). In that study tumors of two xenograft models, respectively, HL-16 cervi-
cal carcinoma and Panc-1 pancreatic carcinoma, were investigated. Significant heterogeneity in IFP was
reported and it was proposed that this was associated with division of tissue into compartments sepa-
rated by thick connective tissue bands for the HL-16 tumors and with dense collagen-rich extracellular
matrix for the Panc-1 tumors. The purpose of the current work is to explore these experimental observa-
tions by using in silico generated tumor models. We consider a mathematical multiphase model which
accounts for tumor cells, fibroblasts and interstitial fluid. The model has been trained to comply with
experimental in vitro results reported in Shieh et al. (2011) which has identified autologous chemotaxis,
ECM remodeling, and cell-fibroblast interaction as drivers for invasive tumor cell behavior. The in silico
model is informed with parameters that characterize the leaky intratumoral vascular network, the per-
itumoral lymphatics which collect the fluid, and the density of ECM as represented through the hydraulic
conductivity of the interstitial space. Heterogeneous distribution of solid stress may result in heteroge-
neous compression of blood vessels and, thus, heterogeneous vascular density inside the tumor. To mimic
this we expose the in silico tumor to an intratumoral vasculature whose net effect of density of blood
vesssels and vessel wall conductivity is varied through a 2D Gaussian variogram constrained such that
the resulting IFPs lie within the range as reported from the preclinical study. The in silico cervical carci-
noma model illustrates that sparse ECM was associated with uniform intratumoral IFP in spite of hetero-
geneous microvascular network, whereas compartment structures resulted in more heterogeneous IFP.
Similarly, the in silico pancreatic model shows that heterogeneity in the microvascular network com-
bined with dense ECM structure prevents IFP to even out and gives rise to heterogeneous IFP. The com-
puter model illustrates how a heterogeneous invasive front might form where groups of tumor cells
detach from the primary tumor and form isolated islands, a behavior which is natural to associate with
metastatic propensity. However, unlike experimental studies, the current version of the in silico model
does not show an association between metastatic propensity and elevated IFP.
 2021 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
1.1. PDAC characteristics
Pancreatic ductal adenocarcinoma (PDAC) patients develop
lymph node metastases early and have a particularly poor progno-
sis. Most PDACs are resistant to chemotherapy and radiation treat-
ment (Castellanos et al., 2011) and surgery is the only treatment
modality that may result in cure (Winter et al., 2012). Metastatic
spread into and through lymphatics and lymph nodes occurs fre-quently in PDAC patients. The microenvironment of PDACs is char-
acterized by an abundant desmoplastic stroma that may occupy up
to 80% of the tumor volume (Whatcott et al., 2015; Bijlsma and van
Laarhoven, 2015; Feig et al., 2012). The PDAC stroma consists of a
dynamic assortment of extracellular matrix components including
fibronectin, collagen, proteoglycans, and hyaluronic acid, nonma-
lignant cells including fibroblasts, endothelial cells, and immune
cells, and soluble proteins such as growth factors and cytokines
(Feig et al., 2012). Recent investigations have revealed that the
PDAC stroma represents a physical barrier to the delivery of
chemotherapeutic agents and simultaneously supports tumor
growth and promotes metastatic dissemination (Whatcott et al.,
2015; Bijlsma and van Laarhoven, 2015; Feig et al., 2012). The
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the architecture of the normal pancreas, resulting in an abnormal
configuration of blood vessels and lymphatics in PDACs
(Mahadevan and Von Hoff, 2007; Fink et al., 2016). Geometric
resistance to blood flow is high in microvascular networks showing
high fractions of low-diameter vessels, resulting in elevated
microvascular pressure. Preclinical and clinical investigations have
revealed that PDACs may show highly elevated interstitial fluid
pressure (IFP) (Provenzano et al., 2012; Chauhan et al., 2014;
DuFort et al., 2016) as well as high fractions of hypoxic tissue
(Dhani et al., 2015; Dhani et al., 2015). The dense desmoplastic
stroma has been suggested to be a determinant of the aggressive
metastatic growth of PDACs (Whatcott et al., 2015; Bijlsma and
van Laarhoven, 2015; Feig et al., 2012). There is some evidence that
PDAC metastasis is promoted by direct interactions between the
parenchymal tumor cells and the cellular and/or matrix compo-
nents of the stroma (Singh et al., 2015; Fokas et al., 2015). It has
been searched for associations between lymph node metastasis
and features of the physicochemical microenvironment in an
attempt to identify mechanisms leading to metastatic dissemina-
tion and growth. Two different xenografts were used as preclinical
models of human PDAC in Andersen et al. (2017). In both models,
lymph node metastasis was associated with high IFP rather than
high fraction of hypoxic tissue or high microvascular density.
1.2. Cervical carcinoma characteristics
The most important tumor-related prognostic factors for cervi-
cal carcinoma are tumor volume, stage of disease, and lymph node
status (Klopp and Eifel, 2012). During growth, cervical carcinomas
develop a highly hostile physicochemical tumor microenviron-
ment characterized by severe hypoxia, interstitial hypertension,
low microvascular density, low extracellular pH, high lactate con-
centration, low glucose concentration, and energy deprivation
(Höckel and Vaupel, 2001; Vaupel and Kelleher, 2012). This
microenvironment causes treatment resistance and promotes
malignant progression of the disease, and during the last decade,
it has become increasingly clear that the prognostic and predictive
values of these microenvironmental abnormalities are significant.
Thus, extensive hypoxia in the primary tumor has been shown to
be associated with locoregional treatment failure and poor
disease-free and overall survival rates in patients with advanced
disease (Höckel et al., 1993; Höckel et al., 1996; Fyles et al.,
1998; Sundfør et al., 2000). Studies of cervical carcinoma patients
treated with radiation therapy alone have shown that high intersti-
tial fluid pressure (IFP) in the primary tumor is linked to high prob-
ability of pelvic recurrence and distant metastases (Milosevic et al.,
2001; Fyles et al., 2006; Yeo et al., 2009). Moreover, the disease-
free and overall survival rates have been shown to be particularly
poor for cervical cancer patients with high lactate concentration in
the primary tumor (Schwickert et al., 1995; Walenta et al., 2000).
Interestingly, Fyles et al. (2006) have measured both IFP and oxy-
gen tension in the primary tumor of more than 100 patients with
advanced cervical carcinoma, and their study showed no correla-
tion between either IFP or hypoxic fraction and established
tumor-related prognostic factors. Furthermore, they observed that
the independent prognostic effect of IFP for recurrence and survival
was strong, whereas the independent prognostic effect of tumor
hypoxia was of borderline significance and was limited to patients
without nodal metastatic growth (Fyles et al., 2006).
1.3. CAFS
Fibroblasts in normal tissue are usually single cells residing in
the interstitial space. Fibroblasts are non-epithelial and non-
immune cells which likely originate from a mesenchymal lineage2
(Croft, 1969). Fibroblasts that are recruited into tumor masses,
called tumor-associated fibroblasts (TAFs) or cancer-associated
fibroblasts (CAFs), are the main cellular components of the sur-
rounding stroma of many solid cancers. Evidently, these CAFs pro-
vide a range of different cytokines, growth factors, tissue
remodeling enzymes and ECM components, all of which regulate
the tumor stroma (Desmouliere et al., 2004; Kalluri and Zeisberg,
2006). Gaggioli et al. (2007) discovered that fibroblasts may act
as leader cells of a collective group of following carcinoma cells.
This would allow cancer cells to retain their epithelial features,
which is observed in solid tumors in vivo and also in vitro (Zheng
et al., 2015; Fischer et al., 2015), while having a mesenchymal-
like cell to lead them to invade the adjacent stroma. Furthermore,
Gaggioli proposed that cancer cells move within paths behind
fibroblasts. These paths are created by the fibroblasts both through
proteolytic activity and force-mediated matrix remodeling
(Barbazán and Vignjevic, 2019). Fibroblast-enhanced tumor cell
migration was investigated by Shieh et al. in the presence of inter-
stitial flow where, similar to Gaggioli et al., the fibroblasts created
tracks within the ECM for cancer cells to follow (Shieh et al., 2011).
Later, Labernadie et al. identified another possible mechanism to
which fibroblasts lead cancer cells, a heterotypic cell–cell adhesion
between the two types of cell. More specifically, there is a direct
mechanical coupling between the fibroblast N-cadherin and the
tumor cell E-cadherin (Labernadie et al., 2017). These two mecha-
nisms have been accounted for and are the subject of investiga-
tions through a mathematical model in Urdal et al. (2019) and
Waldeland et al. (2020) based on a cell-fibroblast-fluid multiphase
formulation. In Urdal et al. (2019) the proposed cell-fibroblast-
fluid model was trained with data from the in vitro experiments
reported in Shieh et al. (2011). A first version of an in silico version
of the model was explored in the recent work (Waldeland et al.,
2020) where focus was on demonstrating how tumor cells can
invade adjacent tissue by using fibroblasts as leader cells. Moti-
vated by the results of Labernadie et al. (2017) direct mechanical
interaction between fibroblasts and tumor cells are included in
the computer model. In addition, the in silico model accounts for
the mechanism that moving fibroblasts may remodel ECM, causing
tumor cells to migrate in the tracks of ECM created by the fibrob-
lasts, as observed in Gaggioli et al. (2007), Shieh et al. (2011),
Schwager et al. (2019).
1.4. Motivation and objective
The purpose of the study reported in Hansem et al. (2019) was
to determine whether tumors may show significant heterogeneity
in IFP in the central region, and moreover, to reveal whether any
heterogeneity may have consequences for the assessment of
microenvironment-induced tumor aggressiveness. The study was
based on the hypothesis that heterogeneous IFP in the central
tumor region, if present, to a large extent is caused by structures
that prevent efficient fluid flow in the interstitial space (i.e., related
to tissue conductivity) in combination with the distorted intratu-
moral vasculature caused by solid stress. Detailed comparative
studies of IFP and tumor histology were carried out using preclin-
ical tumor models, respectively, HL-16 cervical carcinoma xeno-
grafts and Panc-1 pancreatic carcinoma xenografts, known to
show significant intertumor heterogeneity of the extracellular
matrix. At the same time, the occurence of lymph node metastasis
was assessed as a measure of the tumor aggressiveness. It was
found that when IFP of HL-16 and Panc-1 was measured at two dif-
ferent positions in the tumor center, the values could differ by a
factor of up to 1.5 in both tumor models. Moreover, the propensity
of the tumors to develop lymph node metastases was associated
with the higher but not with the lower of the two IFP values. We
are interested in an in silico tumor model that can shed light on
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et al., 2019). Central questions are: (i) Can the in silico model
explain the homogeneous IFP observed for HL-16 cervical carci-
noma when ECM is without compartments and Panc-1 pancreatic
carcinoma when ECM is sparse? (ii) Can the in silico model explain
the IFP heterogeneity observed for cervical carcinoma when com-
partments are present? And why should the dense ECM structure
for pancreatic carcinoma give rise to IFP heterogeneity? (iii) How
does tumor cell invasive migration respond to heterogeneities
associated with the ECM structure and the corresponding IFP?
1.5. Review of some previous modeling
Different models have their own possibilities and limitations,
strengths and weaknesses. The models apply different assumptions
regarding which effects to represent explicitly and which effects to
account for in a more implicit manner. In the following we review
some models that have been explored more lately and also played
a role in shaping the model used in this work. In Wu et al. (2013) a
multiphase approach was used to explore the critical role played
by interstitial fluid (IF) and associated interstitial fluid pressure
(IFP) in solid tumors. A continuous growth model was coupled
with a discrete model for angiogenesis. The role of oxygen and fluid
extravasation was explicitly accounted for. The authors investi-
gated how nonlinear interactions among the vascular and lym-
phatic networks and proliferating tumor cells may influence IFP,
transport of oxygen, and tumor progression. The fluid flow is rep-
resented by Darcy’s law, implying that the IFP is a result of the
draining fluid produced by the leaky blood vasculature and col-
lected by the lymphatic system, and the resistance represented
through the tissue conductivity. Solid stress associated with the
growing tumor is accounted for through the hydrostatic tumor
pressure via a Darcy like equation for the solid phases. The intersti-
tial hydraulic conductivity in the tumor is related to the tumor
ECM density, i.e., higher (lower) hydraulic conductivity is associ-
ated with lower (higher) ECM density. The model has been
extended to account for delivery of an anticancer drug via the
blood vasculature (Wu et al., 2014). In Frieboes et al. (2010) a
dynamic evolving tumor vasculature is combined with multi-
species tumor invasion driven by an interplay between a prolifer-
ating phenotype and a migrating phenotype. The model is based on
mass balance equations for each species and corresponding gener-
alized Darcy laws for the various components where coefficients
involve mobility functions that reflect the combined effects of
cell–cell and cell-matrix adhesion. The model has been used in
the context of Glioblastoma (Yan et al., 2017) to explore tumor pro-
gression and response to anticancer drug. In Jarrett et al. (2020,
2018) and Jarrett et al. (2018) an experimental-mathematical
framework on tissue level is used to integrate quantitative mag-
netic resonance imaging (MRI) data into a biophysical model to
predict patient-specific treatment response of locally advanced
breast cancer to neoadjuvant therapy. Effects accounted for in
the mathematical model are migration by diffusion where the non-
linear diffusion coefficient is coupled to stress calculations, prolif-
eration/apoptosis with a proliferation rate coefficient which is
estimated, and an anti-cancer term that eradicates cancer cells
by contact. A family of biophysical models of tumor growth and
angiogenesis have been developed that are calibrated with
diffusion-weighted magnetic resonance imaging and dynamic
contrast-enhanced MRI data to provide individualized tumor
growth forecasts (Hormuth et al., 2019). The tumor cells as well
as the evolution of the blood vasculature are described by using
two diffusion–reaction equations.
Another, but related type of mathematical model of tumor
growth on tissue level has been formulated in Mpekris et al.
(2015) for the purpose of exploring interconnections among3
(i) tumor oxygenation;
(ii) the heterogeneous accumulation of mechanical stresses
owing to tumor growth;
(iii) the non-uniform compression of intratumoral blood vessels
due to the mechanical stresses;
(iv) and the insufficient delivery of oxygen and therapeutic
agents because of vessel compression.
The authors found that the high vascular density and increased
cancer cell proliferation often observed in the periphery can be
attributed to heterogeneous solid stress accumulation. The mathe-
matical model was based on a biphasic formulation in terms of vol-
ume fractions that account for solid phase and fluid phase with
corresponding different velocities. Source terms associated with
these mass balance equations account, respectively, for the growth
of the solid phase and the drainage of the IF from the leaky tumor
vasculature and collected by the lymphatics through Starling’s law.
A Darcy type equation is used where the difference between solid
and fluid velocity is linearly related to the IF pressure gradient with
the hydraulic conductivity of the tissue as coefficient. A similar
model was used in Angeli and Stylianopoulos (2016) to evaluate
the effect of radiation therapy.
A mathematical model for tumor progression is considered in
Mascheroni et al. (2019) which accounts for microenvironmental
changes that might trigger chemo-mechanically induced cellular
phenotypic transitions. The model is based on diffusion-reaction
equations to describe migrating cancer cells, vascularity density
and nutrient whereas the proliferating cells are represented by
an ordinary differential equation (ODE). An algebraic equation is
used to represent mechanical compression of the cells in a phe-
nomenological way. Reaction terms are included to model that
phenotypic transitions of tumor cells are driven by both chemical
and mechanical effects. A phenotypic transition driven by mechan-
ical pressure is assumed, i.e., compression favors cell migration and
inhibits cell proliferation. The authors analyze the effects of
mechanical compression on the internal balance between migra-
tion and proliferation of glioma cells and the impact on tumor infil-
tration. In Lewin et al. (2020) a three-phase multiphase model is
explored, similar to previous models (Hubbard and Byrne, 2013;
Breward et al., 2002; Byrne et al., 2003), which involves three sep-
arate mass balance equations and corresponding momentum bal-
ance laws. General momentum balance equations are used where
also external force terms are accounted for. The different phases
are tumor cells, dead cellular material, and fluid. Through numer-
ical simulation of the model equations, spatial structures and
dynamics typical of those associated with the growth of avascular
tumour spheroids are investigated.
A biphasic tumor model is used in Mascheroni et al. (2016) that
accounts for the tumor cells and the interstitial fluid. Mechanical
stress on the solid phase (cancer cells) is described by an effective
stress tensor and involves a stress term from IF (isotropic IFP) with
inclusion of Biot’s coefficient and a total stress tensor in the tissue
(matrix/ECM). The effective stress tensor for the solid phase is
given in terms of an isotropic constitutive term (elastic fluid)
which expresses that for low volume fraction of cancer cells, they
tend to attract, for high they tend to repel (Byrne and Preziosi,
2003). In Mascheroni et al. (2017), the model in Mascheroni et al.
(2016) is combined with governing equations for transport and
uptake of a chemotherapeutic agent, acting on cell proliferation.
Model simulations suggest that mechanical compression of tumors
may imply that a drug dose that is effective in reducing tumor vol-
ume for stress-free conditions may not perform equally well in a
mechanically compressed environment. Finally, in d’Esposito
et al. (2018) a 3D mathematical model is explored which combines
a steady state model for vascular flow, IFP, and interstitial fluid,
and a transient model for delivery of a chemical agent through
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work model (similar to Wu et al., 2013; Wu et al., 2014) with
single-phase Darcy’s law and Starling’s law for describing the
exchange of fluid between vasculature and interstitium. It is
demonstrated that by adding realistic, whole-tumor microstruc-
ture with its inherent heterogeneity, accurate predictions of fluid
mechanical aspects of the tumor and delivery of chemical agents
can be achieved.
2. Mathematical model
The mathematical model we use to represent the solid tumors
bears many similarities with previous models. However, motivated
by recent results which emphasize the possible role played by fluid
flow and related forces as a means for cancer cells to seed distant
metastases (Follain et al., 2020), we will inform the model with
experimentally observed fluid-sensitive migration mechanisms,
both for fibroblasts and cancer cells. The proposed model has some
novel features in that respect, to the best of our understanding. In
the following we briefly highlight some similarities and differences
to multiphase models explored by other researchers (Breward
et al., 2002; Byrne et al., 2003; Hubbard and Byrne, 2013; Wu
et al., 2013; Wu et al., 2014; Mascheroni et al., 2016; Mascheroni
et al., 2017; d’Esposito et al., 2018; Lewin et al., 2020; Mpekris
et al., 2015; Angeli and Stylianopoulos, 2016; Weis et al., 2015;
Jarrett et al., 2018; Hormuth et al., 2019). One main focus is on
the coupling between the heterogeneous IF drainage and IFP and
the corresponding aggressive and invasive cancer cell behavior at
the tumor periphery.
2.1. Underlying assumptions and principles for the mathematical
multiphase model
1. We consider three separate phases in terms of cancer cells ac ,
fibroblasts (CAFs) af and interstitial fluid aw which are repre-
sented through separate mass balance equations and momen-
tum balance equations which account for the stress tensor
and external forces for each individual phase (Hubbard and
Byrne, 2013; Lewin et al., 2020).
2. Cancer cells and CAFs are able to generate friction forces and
active traction forces (Alert and Trepat, 2020). To represent
these mechanisms the tissue is considered as a porous medium
composed of a stagnant, rigid solid matrix that essentially rep-
resents the ECM structures whereas the porous space is avail-
able for the cancer cells, CAFs and fluid to move through. This
is accounted for through a porosity /. The momentum balance
laws explicitly represent interaction forces between cancer cells
and CAFs as well as resistance forces (friction) between the dif-
ferent phases and underlying matrix. This allows to account for
fluid-sensitive migration mechanisms (Follain et al., 2020) as
reported in Shieh et al. (2011), Polacheck et al. (2011), Urdal
et al. (2019) that might play a role in invasive behavior and
metastasis during tumor progression (Waldeland et al., 2020).
In particular, the momentum balance for IF involves a Darcy-
type model as used by others (Wu et al., 2013, 2014) who have
explored how the elevated intratumoral IFP is a result of the tis-
sue conductivity and aberrant intratumoral vasculature caused
by solid stress (Mpekris et al., 2015; Angeli and Stylianopoulos,
2016).
3. The intratumoral blood and lymphatic vasculature are modeled
by using a continuum approach based on Starling’s law (Wu
et al., 2013; Wu et al., 2014; Mpekris et al., 2015). However,
we do not explicitly account for angiogenesis and dynamic
changes in the fluid drainage, as done by others. When we sim-
ulate the tumor progression during a period of some days, we4
set the net effect of proliferation and apoptosis to be zero since
proliferation is associated with an evolving vasculature. We
could include such effects but have chosen not to do so since
our motivation is to focus more precisely on how fluid-
sensitive migration mechanisms (Shieh et al., 2011; Polacheck
et al., 2011) might be a driver for invasive behavior and meta-
static dissemination of cancer cells.
4. We explicitly account for solid stress through Pc and Pf , respec-
tively, associated with cancer cells and fibroblasts, similar to
what is done in Frieboes et al. (2010), Wu et al. (2013),
Hubbard and Byrne (2013), Lewin et al. (2020), Mascheroni
et al. (2016), Mascheroni et al. (2017). More precisely,
Pc ¼ Pw þ DP þK where Pw is IFP and DP and K represent stress
generated by the moving cancer cells as they interact with the
surrounding ECM structure through diffusive spreading and
chemotactic migration, respectively, The external interaction
force terms are also involved in this build-up of solid stress.
To mimic that heterogeneous distribution of solid stress may
result in heterogeneous vascular density inside the tumor
(Mpekris et al., 2015), the effective coefficients involved in Star-
ling’s law are varied as a 2D Gaussian variogram (in space) from
one tumor to another. Similarly, we also generate a heteroge-
neous lymphatic network in the peritumoral region.
5. Solid stress may facilitate fibroblasts activation which in turn
promotes pancreatic cancer cell migration (Kalli et al., 2018).
Compressed fibroblasts continuously interact with cancer cells
and induce cancer cell migration possibly through secretion of
fibroblasts-derived factors (Desmouliere et al., 2004; Kalluri
and Zeisberg, 2006). This is accounted for in the model by let-
ting the CAFs represent a phenotype with activated migration
abilities. Also the dense ECM structure, which affects the tissue
conductivity (Wu et al., 2013) as well as intratumoral vascula-
ture might be a result of this solid stress-stimulated fibroblast
activation.
6. Solid stress is reported to be a driver for the development of the
aberrant intratumoral vasculature with high intravascular pres-
sure and high vasculature conductivity reflecting a high degree
of leaky walls (Jain et al., 2014). Solid stress may also suppress
proliferation and promote cancer cell phenotype with higher
degree of viability (Frieboes et al., 2010; Jain et al., 2014;
Mascheroni et al., 2019). Similarly, it has been found that inter-
stitial fluid flow inhibits the proliferation for a pancreatic cell
line while a high viability is maintained (de Haan et al., 2019).
This motivates for our assumption that the cancer cell is a phe-
notype where proliferation has been down-graded and migra-
tion upgraded.
7. For evaluation of the simulation outputs, we first generate an
ensemble of input parameters that characterizes (through Star-
ling’s law) the heterogeneous intratumoral vasculature and per-
itumoral lymphatic network, as well as tissue conductivity. We
use literature values for these parameters to represent their
means combined with stochastic-generated variations con-
strained such that the resulting intratumoral IFP is consistent
with measured values reported in Hansem et al. (2019). A moti-
vation for this approach is that it represents the first step in an
assimiliation-based method (Aanonsen et al., 2009) where
observed data (e.g., from MRI) can be used to calibrate model
parameters (Jarrett et al., 2018; Hormuth et al., 2019).
2.2. Cell-fibroblast-fluid model
A brief presentation of the model is given as details can be
found elsewhere (Urdal et al., 2019; Waldeland et al., 2020)
(Appendix A). Note that / is the volume fraction occupied by the
pore space through which the cells and fluid can move whereas
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ematical model takes the following form using variables as
summed up in Table 1:
/acð Þt þr  /acucð Þ ¼ Sc
/af
 
t þr  /afuf
  ¼ Sf ; ac þ af þ aw ¼ 1
/awð Þt þr  /awuwð Þ ¼ Sc  Sf þ Q ; Q ¼ Qv  Ql
acr Pw þ DPcw þKCð Þ ¼ f̂cuc þ f̂cf uf  uc
 
afr Pw þ DPfw þKH
  ¼ f̂fuf  f̂cf uf  uc 
awrPw ¼ f̂wuw
/awCð Þt ¼ r  DCrCð Þ  r  /awCuwð Þ þ QC
/awHð Þt ¼ r  DHrHð Þ  r  /awHuwð Þ þ QH
ð1Þ
where ui ¼ uxi ;uyi
 
for i ¼ c; f ;w. Since / is here assumed to be con-
stant it can be incorporated in the dimensionless time and grouped
with the velocities uc;uf ;uw (Waldeland et al., 2020) (Appendix A).
Eq. (1)13 represent, respectively, the mass balance equations for
cancer cells, fibroblasts and interstitial fluid. The next three equa-
tions, (1)46, are the corresponding momentum balance equations
(Hubbard and Byrne, 2013; Lewin et al., 2020). The RHS of (1)4 is
separated into two terms: f̂cuc represents the resistance against
migration felt by cancer cells from the ECM whereas f̂cf uf  uc
 
represents the interaction force between fibroblasts and cancer
cells. Here we have ignored a cell-fluid interaction term of the form
f̂cw uw  ucð Þ, respectively, in (1)4 and (1)6. This is based on the
experimental finding that cancer cells did not enhance migration
due to fluid flow alone, only in the presence of both fluid flow
and chemotaxis (Shieh et al., 2011). For the same reason, the
fibroblast-fluid interaction term f̂fw uw  uf
 
is also ignored,
respectively, in (1)5 and (1)6 (Urdal et al., 2019). For a theoretical
justification we refer to Giverso et al. (2015). Solid stress associated
with the cell phase is Pc ¼ Pw þ DPcw þKC , similar to what has been
used by others (Frieboes et al., 2010;Wu et al., 2013; Hubbard and
Byrne, 2013; Lewin et al., 2020; Mascheroni et al., 2016;
Mascheroni et al., 2017). Herein, DPcw acð Þ quantifies a stress in the
cell phase associated with a diffusive migration. The potential func-
tion KC Cð Þ represents additional stress that accounts for chemotaxis
toward higher concentrations of chemokine C. Similarly, the RHS of
(1)5 accounts for fibroblast-ECM interaction and cell-fibroblast
interaction, respectively, whereas solid stress associated with the
fibroblasts is Pf ¼ Pw þ DPfw þKH . Herein, DPfw af
 
accounts for dif-
fusive migration whereas the potential function KH Hð Þ accounts forTable 1
Variables used in the model (1).
Variable Description
/;ac ;af ;aw Tissue porosity, volume fraction of cell, fibroblast,
fluid
Sc ; Sf cell growth/death
uc ;uf ;uw interstitial cell, fibroblast and fluid velocity
C;H chemokine, TGF
Pw; Pc ; Pf IF pressure, solid stress associated with cancer cell,
fibroblast
DPfw;DPcw;KC ;KH caf-caf, cell–cell, chemokine, TGF chemotactic stress
f̂c ; f̂f ; f̂w; f̂cf cell-ECM, fibroblast-ECM, fluid-ECM, cell-fibroblast
interaction terms
Qv ;Ql produced fluid from leaky vasculature, collected fluid
through lymphatics
Tv ; Tl effective conductivity of vascular vessel wall,
lymphatic vessel wallePv ; ePl effective vascular pressure, lymphatic pressure
DC ;DH diffusion coefficients associated with C;H
QC ;QH production/decay rates associated with C;H
Xv ;Xl region of intratumoral vascular, peritumoral
lymphatic network
5
chemotaxis of fibroblasts towards positive gradients in growth fac-
tor H. The fluid momentum balance through (1)6 amounts to
Darcy’s law (Wu et al., 2013; Wu et al., 2014; d’Esposito et al.,
2018). The two remaining equations, (1)7,8, are transport-reaction
equations for chemokine and TGF, respectively. Rate terms for pro-
duction/decay of C and H are given by QC and QH and are specified
in Table 2. The values used for different rate terms kij are given in
Table 8 (Appendix) and is based on the calibration done in Urdal
et al. (2019) to mimic the experimental results reported in Shieh
et al. (2011).
Remark 2.1. The description of how chemokine is produced has
been simplified in the model (1) as compared to previous versions
of the model (Urdal et al., 2019; Waldeland et al., 2020). This
allows us to reduce the number of variables and parameters
involved in corresponding rate equations and at the same time
maintain the essential mechanism as reported from experimental
work (Shieh et al., 2011). Namely, that chemokine and growth
factor are transported by the fluid velocity field and tend to
accumulate nearby peritumoral lymphatic vessels which drain the
excess fluid.2.3. Interaction coefficients
The interaction coefficients f̂w; f̂c; f̂f , and f̂cf which are used in
(1)46 are as follows (Urdal et al., 2019; Waldeland et al., 2020;
Qiao et al., 2018; Qiao and Evje, 2020):
f̂w ¼ Iwk̂w/arww ; f̂c ¼ Ick̂c/arcc ; f̂f ¼ If k̂f/a
rf
f ;
f̂cf ¼ Icf/arcfc arfcf : ð2Þ
The parameters Iw; Ic and If Pas=m2
 
represent static properties
of the tissue, whereas k̂w; k̂c and k̂f (dimensionless) can account for
dynamic properties related to for instance ECM remodeling and
fiber alignment or various ECM heterogeneities (Shieh et al.,
2011). The coefficients rw; rc; rf ; rcf and rfc (dimensionless) play a
similar role to the use of relative permeability functions in stan-
dard Darcy’s equation approach extended to several phases (Evje,
2017; Qiao et al., 2018; Qiao and Evje, 2020). Icf is a constant deter-
mining the order of magnitude of the cell-fibroblast interaction.
We use Icf ¼ 1000Iw to describe how strongly the cancer cells are
mobilized through their interaction with surrounding fibroblasts.
As Icf becomes larger, the difference between fibroblast and cancer
cell velocity becomes smaller, ultimately converging toward zero
(Urdal et al., 2019). We assume that fibroblasts remodel and
degrade the ECM, making it easier for the cancer cells to migrate
in their path. This is represented through the following equation:
k̂c ¼ 1 A 1 exp Baf
  
; A;B are dimensionless constantsð Þ:
ð3Þ
The values used for the different parameters involved in (2) and
(3) are presented in Table 7 (Appendix A). These are based on the
calibration done in Urdal et al. (2019) to mimic the experimental
results reported in Shieh et al. (2011). Compared to previous use
of the model (1), we have to account for band-like structures inTable 2
Source terms in (1)7,8 accounting for production/decay of chemokine and
growth factor.
Function Description
QC = acaf k11  k12 CCM
 mC  k13acC MCQlC




k24af H  k25H MHQlH
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like structures in the conductivity-related coefficient k̂w. Details
are given in Section 3.
2.4. Starling law
In nearly all tissue, plasma leaks out of blood capillaries, flows
through the interstitium and drains into lymphatic vessels, where
it passes through lymph nodes before being returned to the venous
blood (Jain et al., 2014). This circulation is expressed on the RHS of
(1)3 through the term Q ¼ Qv  Ql. The main contributors to inter-
stitial flow Qv are hydrostatic and osmotic pressure gradients
between the vascular and interstitial space. Starling Law is used
for the flow of fluid into the interstitium given by Frieboes et al.
(2010), Wu et al. (2013), Wu et al. (2014), Mpekris et al. (2015),
Angeli and Stylianopoulos (2016), d’Esposito et al. (2018)
Qv ¼ Tv Pv  Pw rT pv pw
  ¼ Tv ePv Pw  Tv ¼ Lv SvV ð4Þ
where ePv ¼ Pv  rT pv  pw . Here Lv is the hydraulic conductivity
(m2s/kg = m/Pa s) of the vessel wall, Sv /V (m1) the exchange area of
blood vessel per unit volume of tissues V. Pv and Pw are the vascular
and interstitial fluid pressure, pv and pw the osmotic pressure in the
vascular and interstitial space, and rT the osmotic reflection coeffi-
cient for plasma proteins. The lymphatic system drains excessive
fluid from the interstitial space and returns it back to the blood cir-
culation, as expressed by Ql. Tumor lymphatics in cancers are typ-
ically not functional in the intratumoral region (Jain et al., 2014;
Wu et al., 2013; Wu et al., 2014). The loss of functionality is caused
by compressive solid stress that is developed in tumors. Through
this stress the intratumoral lymphatic vessels collapse, and there-
fore lymphatic flow is eliminated. Similar to the expression of Qv
in (4), we use an expression of the following form to express the
absorption of fluid through the lymphatics
Ql ¼ Tl Pw  ePl ; Tl ¼ Ll SlV : ð5Þ
Here Ll is the hydraulic conductivity of the lymphatic vessel walls
whereas Sl/V is the surface area of the lymphatic vessel per volume
unit of tissues V and ePl is the effective lymphatic pressure.
2.5. Cancer cell and CAF velocities
From (1) an expression for the interstitial cell velocity uc , caf
velocity uf , and IF velocity uw can be derived (Urdal et al., 2019;
Waldeland et al., 2020):
uc ¼ f̂ cac UT|ffl{zffl}
ið Þ
 ĥ1 þ ĥ2
ac
r DPcw acð Þð Þ|fflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflffl{zfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflffl}
iið Þ
 ĥ1 þ ĥ2
ac












ð6Þuf ¼ f̂ faf UT þ
ĥ2
af




 ĥ2 þ ĥ3
af
r DPfw af
   ð7Þuw ¼ f̂ waw UT þ
ĥ1
aw




 þKH Hð Þ : ð8Þ6
We refer to Table 6 (Appendix A) for more information related
to the functions f̂ c; f̂ f , and ĥ1; ĥ2; ĥ3. It follows that these functions
depend directly on the correlations (2). The terms on the RHS of (6)




(iii) Chemotaxis of cells toward higher concentration gradients
in chemokine
(iv) Migration due to fibroblast chemotaxis towards higher con-
centration gradients in TGF
(v) Migration due to fibroblast diffusion.
Fluid generated stress (i) represents a co-current transport
effect, where the two phases of cancer cell and fluid move in the
same direction. The next term (ii) represents diffusive migration
of tumor cells whereas (iii) accounts for directional migration of
tumor cells towards higher concentration of chemokine C. The
two last terms (iv) and (v) represent CAF-dependent migration as
a result of the mechanical interaction between cancer cells and
fibroblasts, as fibroblasts move in the direction of higher concen-
tration of TGF H and spread by diffusion, respectively.
Remark 2.2. In the current work the proposed model (1) has been
constructed such that it can account for the experimental observed
interplay between fibroblasts and cancer cells under the influence
of the outgoing fluid flow field (Shieh et al., 2011). However,
fibroblasts are also known to play a central role in remodelling of
the ECM structure. Hence, an interesting and relevant research task
could be to couple the fibroblast phase to remodelling of ECM. ECM
structures are accounted for through the fluid-ECM interaction
term f̂w suggesting that this term somehow should sense the
fibroblast activity. Such effects are ignored in the current version of
the cell-fibroblast-fluid model as focus is on exploring through a
mathematical model how fibroblasts may act as leader cells of a
collective group of following tumor cells (Gaggioli et al., 2007). In
particular, we seek to put to a test the potential metastatic
mechanism involved when cancer cells retain their epithelial
features (Zheng et al., 2015; Fischer et al., 2015), while having a
mesenchymal-like cell to lead them to invade the adjacent stroma.2.6. Summary of the essential aspects of the in silico tumor model
We give a short summary of the mechanisms of the model
which indicates how the model can represent different aspects
mentioned in the introduction. The computer model has been
trained to comply with experimental in vitro results reported in
Shieh et al. (2011) which has identified autologous chemotaxis,
ECM remodeling, and cell-fibroblast interaction as drivers for inva-
sive tumor cell behavior. This was achieved by first setting the
fluid-ECM resistance force through f̂w such that reasonable patho-
logical values are obtained for IF velocity (i.e., 0:1 1 lm=s) and
IFP. Secondly, the cell-ECM resistance force coefficients f̂c and f̂f
are set such that cancer cells and fibroblasts largely can resist
the force from the flowing fluid in accordance with the experimen-
tal observations. Thirdly, parameters that determine the strength
of the chemotactic migration of fibroblasts and cancer cells
through KC and KH , respectively, as well as the internal cell-
fibroblast interaction f̂cf , are set such that the migration of fibrob-
lasts and cancer cells can mimic the experimental results in Shieh
et al. (2011). The parameters are given in Table 7 and 8 (Appendix
A) and characterize the aggressiveness of the assumed cell pheno-
type. Moreover, the computer model is informed with data per-
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tumoral collecting lymphatic network, and the density of ECM as
represented through the hydraulic conductivity of the interstitial
space motivated by observations from the xenograft models
reported in Hansem et al. (2019). To comply for the situation that
heterogeneous distribution of solid stress may result in heteroge-
neous compression of blood vessels and, thus, heterogeneous vas-
cular density inside the tumor, we generate coefficients Tv and Tl
through a 2D Gaussian variogram but constrained such that the
resulting intratumoral IFP lies within a pathological reasonable
range (Hansem et al., 2019). Main mechanisms that drive the
tumor progression in (1) are:
 Fluid is produced from the leaky vascular system residing near
the periphery of the initial tumor and is absorbed by lymphatics
found in the region outside of the primary tumor, characterized
by the source terms in (1)3 given by Q ¼ Qv  Ql. The resulting
fluid flow field is directed from the vascular to the lymphatic
system (Hompland et al., 2012; Wu et al., 2013; Wu et al.,
2014; d’Esposito et al., 2018). Tumors develop elevated IFP
because they show high resistance to blood flow (i.e., ePv in (4)
is high), low resistance to transcapillary fluid flow (i.e., Tv in
(4) is high), and impaired lymphatic drainage (i.e., Ql in (5) is
located to the peritumoral region).
 Growth factor H (TGF) is secreted by fibroblasts af and chemo-
kine C is secreted from cancer cells combined with fibroblast
activity, as described by (1)7,8. These chemical components dif-
fuse and advect with the fluid flow through uw, creating chem-
ical gradients downstream of the flow (Shieh et al., 2011).
Cancer cells and fibroblasts migrate towards positive gradients
of their respective chemotactic chemical, chemokine C and
transforming growth factor (TGF) H. Chemotaxis is represented
through the potential functions KC and KH appearing in (1)4,5.
Hence, the model accounts for autologous chemotaxis which
has been observed fromin vitroexperiments (Shieh et al., 2011;
Polacheck et al., 2011; Polacheck et al., 2014) and proposed as
a possible mechanism for guiding tumor cells toward lymphat-
ics (Fink et al., 2016; Andersen et al., 2017; Hompland et al.,
2012). Expression of the chemokine CCL21 in lymphatic vessels
correlated with increased lymph node metastasis in pancreatic
patients (Guo et al., 2013; Sperveslage et al., 2012), as did over-
expression of CCR7 in pancreatic tumor cellsin vivo (Sperveslage
et al., 2012) and supports the choice of autologous chemotaxis
as a driver for tumor cell dissemination in the computer model.Fig. 1. Tumor cell and fibroblast status when the simulation of the in silico tumor mo
tumor, having a constant volume fraction of 0.3. The red contour line shows a volume fra
generated through a Gaussian variogram, yielding random volume fractions around the
7
 A large resistance force is imposed on the cancer cells making it
difficult for them to migrate on their own, i.e., the cell-ECM
interaction coefficient f̂c in (2) takes a large value. This is neces-
sary to rule out the unrealistic behavior that cancer cells move
only due to the push from the flowing fluid (Waldeland and
Evje, 2018). Fibroblasts, on the other hand, are considered much
more mobile, e.g. due to the tumor induced solid stress (Kalli
et al., 2018). Fibroblasts reduce the resistance to migration
experienced by cancer cells through the functional form of k̂c
given by (3). Cancer cells may attach themselves onto fibrob-
lasts and/or follow tracks where fibroblasts have migrated due
to the diminished resistance in their wake. This yields a largely
fibroblast-dependent cancer cell migration, consistent with
experimental observations (Gaggioli et al., 2007; Shieh et al.,
2011; Labernadie et al., 2017).
3. Results







Hj@X ¼ 0; t > 0 ð9Þ
where m is the outward normal on the domain @X with
X ¼ 0;2½   0;2½  (dimensionless) and PB is atmospheric pressure.
The corresponding initial data are
ac x; t ¼ 0ð Þ ¼ ac0 xð Þ; af x; t ¼ 0ð Þ ¼ af0 xð Þ;
C x; t ¼ 0ð Þ ¼ H x; t ¼ 0ð Þ ¼ 0: ð10Þ
For more details on the numerical method we use, we refer to
Appendix B.
3.1. Initial volume fraction of fibroblasts and tumor cells
The initial volume fraction of tumor cells, i.e., the primary
tumor is shown in Fig. 1(A). An example of the initial fibroblast dis-
tribution is illustrated in Fig. 1(B). (A) shows the primary tumor at
time t ¼ 0 having a cancer cell volume fraction equal to approxi-
mately 0:3 in the center and quickly decreasing towards the
periphery. This can be considered an ideal tumor whose margin
is smooth and has no heterogeneity or indication of metastatic
propensity. The fibroblast volume fraction in (B) is somewhat
heterogeneous. Fibroblasts are assumed to surround the tumor in
a bandlike region (Von Ahrens et al., 2017; Lakiotaki et al., 2016).
The fibroblast volume fraction is generated randomly as a Gaussiandel starts. (A) Initial cancer cell volume fraction. It is assumed the tumor is an ideal
ction of 0.01. (B) Initial fibroblast volume fraction. The distribution of fibroblasts are
tumor.
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ECM status that is not accessible. Simulations are done subject to
the condition that the net effect of cell proliferation/apoptosis is
zero, i.e., Sc ¼ Sf ¼ 0 in (1)1,2,3. This amounts to a situation where,
e.g., solid stress may suppress proliferation and promote cancer
cell phenotype with higher degree of viability (Frieboes et al.,
2010; Mascheroni et al., 2019). Simulations are done by using a
grid of 61 61 numerical grid blocks.3.2. Model input parameters
The workflow when we apply the in silico tumor model is com-
posed of two steps: (i) First, we assume that the tumor cells are
equipped with migration mechanisms as found from in vitro stud-
ies (Shieh et al., 2011) as discussed in Urdal et al. (2019) and
reflected by (6) and (7).
The chosen set of parameters found in Table 6–8 (Appendix A)
may be considered as characteristic for the aggressiveness of the
assumed phenotype.
These parameters are kept fixed, except that we will vary the
parameters k2if g5i¼1 involved in (1)8 (see Table 2) which control
the preduction/consumption of the growth factor H. The purpose
is to demonstrate an inherent mechanism for metastatic behavior
where isolated groups of cancer cells are formed. This parameter
vector controls to what extent a more heterogeneous distribution
of the growth factor H may occur. In contrast, the parameter vector
k1if g3i¼1 which effects the production/consumption of chemokine
has much less impact on the tumor cells at the tumor margin since
cancer cell mobility is directly linked to the fibroblasts, as explicitly
expressed through f̂c; k̂c and f̂cf .
(ii) Second, the possible heterogeneous variation in vascular
density and ECM structure, as reflected by the in vivo experimental
observations in Fig. 2 (A,B,E,F), is accounted for by letting parame-
ters associated with the tissue conductivity and the vascular net-
work vary.Further details follow.3.3. Intratumoral vascular network, peritumoral lymphatic network,
and tissue conductivity
The in silico model (1)–(5) is informed with parameters that
characterize the leaky intratumoral vascular network, as expressed
through Tv and ePv in (4), the peritumoral lymphatics as expressed
through Tl and ePl in (5), and the density of ECM as represented by
the hydraulic conductivity of the interstitial space through k̂w
involved in the fluid-ECM interaction term f̂w in (2). For the filtra-
tion coefficientsTv and Tl we use mean values similar to values
reported in the literature (Baxter and Jain, 1989; Wu et al., 2013)
combined with stochastic-generated variations through a 2D Gaus-
sian variogram constrained such that the resulting IFPs vary within
the range reported in Hansem et al. (2019). More precisely, we set
maximal intravascular pressure ePv ¼ 6000 Pa (45 mmHg) and
inner lymphatic pressure ePl ¼ 600 Pa (4.5 mmHg). This typically
gives a minimum IFP around -2 mmHg in the peritumoral region
which is within the range of 3 to + 3 mmHg assumed for normal
tissues (Lunt et al., 2008; Hansem et al., 2019). The other variables
k̂w; Tv and Tl for the case with cervical carcinoma are varied as indi-
cated in Table 3. IFP values are then acquired that are around 10–
40 mmHg, as seen in Fig. 2 (C). We note that Iwk̂w
 1
amounts to
the hydraulic conductivity and takes for the sparse case values in
the interval 1:25 5½   1013 (m2=Pas). This is in the upper range
of values used, for example, in Baxter and Jain (1989) and Wu
et al. (2013) which vary from 0:64  1014 till 0:31  10138
(m2=Pas). On the other hand, in the case with dense ECM,
Iwk̂w
 1
varies in the interval 3:3 10½   1014 (m2=Pas), see
Table 4. Moreover, TvT
 varies within 0:1 4½   103 (1=Pa) for
the sparse case which is comparable to values used by others,
e.g., Baxter and Jain (1989) and Wu et al. (2013) where
TvT
 ¼ 4:2  103 (1=Pa). Slightly lower values are used for the
dense case (Table 4).3.4. In silico tumor representing cervical carcinoma with
homogeneous/compartmentalized ECM
We consider an ensemble composed of 50 realizations of k̂w; Tv ,
and Tl within the range as specified in Table 3 (sparse) to mimic the
situation shown in Fig. 2 (panel A and E) with homogeneous ECM
and Table 3 (compartments) to mimic the situation shown in Fig. 2
(panel B and F) with compartments. We represent the tumor his-
tology in Fig. 2 E and F through our parameter that accounts for
the resistance to fluid flow, k̂w. The experimental case with homo-
geneous ECM is translated into a uniform k̂w (panel G), whereas the
compartment case is represented by high value k̂w bands (panel H).
The spatial distribution related to Tv has a Gaussian variogram
with practical range of 30 voxels in x and y direction. TvT
 (where
T is the reference time, see Table 5 in Appendix A) has a standard
deviation of 0:5  103 and a mean value of 2  103. Meanwhile, the
spatial distribution of TlT
 has a Gaussian variogram with practical
range of 2 voxels in x and y direction. Each tumor has a different
standard deviation and mean value, ranging from 104  103
and 5  105  5  104 for the standard deviation and mean value,
respectively. See Fig. 3(B) for a typical example.
The distribution of the corresponding different IFPs, as gener-
ated by the in silico model and evaluated at two different, fixed
positions in the intratumoral region, is shown in Fig. 2 (panel C).
We use the notation ”ventral” IFP and ”dorsal” IFP which refer to
two fixed positions in the 2D domain, respectively, corresponding
to the grid box 29;29ð Þ and grid box 33;33ð Þ on a grid of 61 61
grid blocks. This mimics what was done in Hansem et al. (2019)
where IFP was measured at two different positions. Comparison
with Fig. 2 (panel A) reveals that the in silico cervical model largely
behaves similarly to thein vivoresult (Hansem et al., 2019) showing
a homogeneous intratumoral IFP. Moreover, for the compartment
case shown in Fig. 2 (panel D) the resulting IFP distribution is much
more heterogeneous, similar to the experimental results in Fig. 2
(panel B). As seen from Table 3, the main difference between the
two cases is that k̂w for homogeneous ECM can vary within a small
interval whereas for the case with arbitrary, high-resistant bands
k̂w will take a very high value where the bands are located. Next,
we want to illustrate more details by exploring one of the in silico
models shown in Fig. 2, first for the case with homogenous ECM
(panel C), then for the case with compartments (panel D). We
use one of the high pressure tumors found in Fig. 2 (C) as our
homogeneous case, without any other preferences than the high
pressure. The corresponding tumor with compartments, which
has the same parameters except for the inverse tissue resistance
k̂w, is also used.3.4.1. Homogeneous ECM, high maximal IFP
For this instance we find that the maximal IFP is around 29
mmHg whereas the ”measured” dorsal pressure is 27 mmHg and
ventral pressure is 28 mmHg. The simulated growth of this in silico
model is then computed up to T ¼ 50 (around 5.8 days). In Fig. 3 is
an illustration of Tv (panel A), and Tl (panel B). Heterogeneity is
seen both for Tv and Tl. Moreover, in Fig. 4 the resulting interstitial
Fig. 2. HL-16 cervical carcinom. Experimental results for (i) homogeneous ECM (A, E); (ii) ECM with compartments (B, F). A, B IFP measured at two different locations within
a tumor for a total of 15 tumors in both A and B, for homogeneous ECM seen in E and ECM with compartments seen in F, respectively. The coefficient of determination for the
two plots in A and B is R2 ¼ 0:97 and R2 ¼ 0:49 respectively. IFP measurements at two locations using 50 simulated tumors are shown in C and D, with corresponding example
tumors seen in G and H, which are considered representative for E and F. Panels (A), (B), (E) and (F) were reproduced from Hansem et al. (2019) [DOI: 10.1016/
j.tranon.2019.05.012].
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Table 3
Parameters characterizing the TME of cervical carcinoma.
Case Variable Description Values
Sparse k̂w fluid-ECM resistance force 1 4½  (*)
TvT
 effective vasculature conductivity 1  104  4  103 (1=Pa) (**)
TlT
 effective lymphatic conductivity 1  104  2  103 (1=Pa)
Compartments k̂w fluid-ECM resistance force 1;100f g
TvT
 effective vasculature conductivity 1  104  4  103 (1=Pa)
TlT
 effective lymphatic conductivity 1  104  2  103 (1=Pa)
(*)
Iwk̂w
 1 hydraulic conductivity 1:25 5½   1013 (m2=Pas)
(**) Tv ¼ Lv SvV Lv ¼ 2:8  107 (cm=mmHgs) 4:2  107 (1=Pas)
Sv
V ¼ 200 (cm1) (reference (Baxter and Jain, 1989; Wu et al., 2013))
Table 4
Parameters characterizing the TME of pancreatic carcinoma.
Case Variable Description Values
Sparse k̂w fluid-ECM resistance force 1 4
TvT
 effective vasculature conductivity 1  104  4  103 (1=Pa)
TlT
 effective lymphatic conductivity 1  104  2  103 (1=Pa)
Dense k̂w fluid-ECM resistance force 5 15 (*)
TvT
 effective vasculature conductivity 1  104  1:5  103 (1=Pa)
TlT
 effective lymphatic conductivity 1  104  2  103 (1=Pa)
(*)
Iwk̂w
 1 hydraulic conductivity 3:3 10½   1014 (m2=Pas)
Fig. 3. Parameters characterizing the vascular and lymphatic system, homogenous ECM: (A) Vascular filtration constant Tv . The vascular system is placed at the periphery
of the primary tumor. (B) Lymphatic filtration constant Tl where the lymphatic network is placed in the peritumoral region. The vascular and lymphatic field are both
generated through a Gaussian variogram, creating random fields. The filtration constants are multiplied by T to yield the unit 1=Pa½ .
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ity field uw is illustrated in panel B. In particular, we observe that
the heterogeneity associated with the leaky vascular system
through Tv does not lead to heterogeneous IFP. In panel C and D
the corresponding invasive tumor cell and fibroblast behavior are
illustrated. Cancer cells (panel C) are themselves fairly immobile
due to the high cell-ECM resistance force through the parameter
Ic , see Table 7 (Appendix A). Yet, when following fibroblasts (panel
D) through direct attachment and/or created tracks they become
much more mobile. A strong core of cancer cells remains, as shown
in panel C. There are, however, cancer cells following fibroblasts
and therefore migrate in sheets away from the primary tumor with10some tendency to create strands and islands. Considering the
chemical concentration profiles, panel E (chemokine) and panel F
(TGF), positive chemical gradients are formed in the vicinity of
the lymphatic network which trigger fibroblasts and cancer cells
to move outwardly from the primary tumor.
The migration pattern seen in Fig. 4 does not fully explain the
possible metastatic behavior where groups of tumor cells are able
to detach from the primary tumor.
As an illustration of the potential aggressive behavior involved
in the cell-fibroblast interaction, we modify the parameters
k2if g5i¼1 involved in (1)8 to give a more heterogeneous distribution
of the growth factor H. This, will in turn make the migration of
Fig. 4. Simulation results, homogenous ECM: (A) Interstitial fluid pressure in mmHg. The pressure is largest within the tumor due to the leaky vascular system, and
decreases quickly at its margin. (B) Fluid velocity field. The fluid originates from the primary tumor and is flowing towards the lymphatics. The effectiveness of the collecting
peritumoral lymphatics determines how far the fluid will flow out from the tumor margin. (C) Tumor cell volume fraction at the end of the simulation. Ihe invasive front is
fairly regular. The red circle shows the initial tumor cell volume ac ¼ 0:01. The white line is also tumor cell volume fraction ac ¼ 0:01, illustrating the invasive front after
simulated period. (D) Fibroblast volume fraction at the end of simulation. The fibroblasts have not migrated far from their initial position seen in Fig. 1 (B). (E) Distribution of
chemokine, which is secreted by the tumor cells, is transported through the pore space and is causing tumor cell chemotaxis towards the lymphatics. (F) TGF is produced by
fibroblasts and is transported through the pore space. Fibroblasts chemotact towards positive gradients in TGF.
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k2 ¼ 4  107;2  107;4  107;4  1010;2  105
 
, see Table 8
(Appendix A) for comparison with default values. Both the level
of production and consumption of the growth factor are reduced.
The result is shown in Fig. 5. The change in migration pattern is
striking: isolated groups of fibroblasts have formed (panel B) with
corresponding isolated islands of tumor cells as well as strands of
infiltrating tumor cells (panel A). If we were to consider a tumor
with homogeneous histology having low maximal IFP, we gener-
ally see less heterogeneous invasion into the tissue compared to
Fig. 4C (data not shown). How far into the tissue the tumor cells
invade does not change when the IFP is reduced, yet the results
show different tumor cell distribution at the invasive front.
3.4.2. Compartmentalized ECM, high maximal IFP
We use Tl as for the homogeneous case discussed above but
now ECM contains compartments which affect Tv . In Fig. 6 is an11illustration of Tv (panel A) and Tl (panel B). k̂w is as shown in
Fig. 2 (H) and reflects the compartmentalized ECM structure which
bears similarity to what is seen experimentally in Fig. 2 (panel E).
The simulated progression of the corresponding in silico model is
then computed up to T ¼ 50 (around 5.8 days). The resulting two
”measured” IFPs are, respectively, 26 and 29 mmHg, while the
maximal IFP is closer to 31 mmHg. In Fig. 7 the resulting interstitial
fluid pressure (IFP) Pw is shown in panel A whereas the fluid veloc-
ity field uw is illustrated in panel B. We observe that a considerably
more heterogeneous IFP is generated within the tumor as com-
pared to Fig. 4A. Other observations are:
 We have assumed the same distribution of the peritumoral
lymphatics through Tl as before, see Fig. 6B. However, the vas-
cular distribution through Tv , (A), is now dependent on the loca-
tion of thick ECM bands, causing low fluid production from the
vessels within the bands.
Fig. 5. Increased aggressiveness, homogeneous ECM: The production/consumption of TGF is now altered to yield a more heterogeneous distribution in the tissue. (A)
Cancer cell volume fraction. Compared to the case in Fig. 4 (C), the tumor cells invade further into the normal tissue while also acting more heterogeneous. (B) Fibroblast
volume fraction. The fibroblasts play an important role in causing tumor cell migration to be more aggressive. (C) Chemokine concentration C shows a similar pattern as in
Fig. 4 but with a lower concentration (E). (D) Transforming growth factor concentration, H, is now much more heterogeneous, which causes the fibroblasts to chemotact in
different directions and in terms of isolated groups.
Fig. 6. Parameters characterizing the vessel system, compartmentalized ECM: (A) Vascular filtration constant Tv . The ECM bands affect the filtration constant Tv ,
decreasing it to very low values within the bands. (B) Lymphatic filtration constant Tl is the same as for the homogenenous case, seen in Fig. 3 (B).
Jahn Otto Waldeland, Jon-Vidar Gaustad, E.K. Rofstad et al. Journal of Theoretical Biology 526 (2021) 110787 The tumor cell migration behavior seen in Fig. 7C largely is a
result of the CAFs migration behavior, as reflected in Fig. 7D.
The invasion front is quite heterogeneous. In the north-west
direction an isolated island of tumor cells have evolved. The dis-12tribution of chemokine and TGF (which play a role in the
chemotaxis of tumor cells and CAFs, respectively) is shown in
panel E and F. The distribution is largely a result of the IF veloc-
ity field shown in Fig. 7B. The simulation suggests that the more
Fig. 7. Simulation results, compartmentalized ECM: (A) Interstitial fluid pressure in mmHg. The IFP is highly heterogeneous throughout the tumor due to the
compartments. The compartments have the effect of preventing the IFP to even itself out within the tumor. (B) Interstitial fluid velocity which correlates with the ECM
structure and IFP distribution. Since the pressure is quite heterogeneous with locally elevated pressures caused by ECM bands with very high resistance to fluid flow, the fluid
velocity field also becomes heterogeneous. There are peaks in fluid velocity where fluid may exit the tumor and is not blocked by the ECM bands seen in Fig. 2 (H). (C) Tumor
cell volume fraction at the end of the simulation. At the upper part of the tumor it is evident that some tumor cells have formed an isolated island. Invasive fingers are about to
evolve to the right. (D) Fibroblast volume fraction distribution is fairly heterogeneous in its invasion into the tissue and correlates with the distribution of TGF. (E) The
chemokine distribution is a result of the heterogeneous IF velocity field. Higher concentrations are seen in regions where flow velocity is low. (F) TGF shows a heterogeneous
distribution which correlates to the IF velocity field. This causes a more heterogeneous migration pattern of the fibroblasts which is transmitted to cancer cells in contact with
fibroblasts.
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the presence of the different compartments has triggered this
metastatic behavior.
 We increase the heterogeneity in growth factor distribution by
changing k2if g as for the previous case. The resulting behavior of
the in silico model is shown in Fig. 8. Again, we see that the col-
lective outgoing groups of CAFs (panel B) trigger a more aggres-
sive tumor cell migration behavior resulting in strands and
islands (panel A).
If we were to use a case with low maximum IFP, we typically
see less heterogeneous invasion into the tissue. The low IFP causes
less room for heterogeneous pressure between the different com-
partments and therefore the tumor migration is also less
heterogeneous.133.5. In silico tumor representing pancreatic carcinoma with
sparse/dense ECM
Now we focus on the experimental findings for pancreatic can-
cer reported in Hansem et al. (2019). The situation shown in Fig. 9
(panel A and E) for Panc-1 pancreatic carcinoma xenograft model
with sparse ECM bears similarities to the case with HL-16 cervical
carcinoma with homogenous ECM, which was explored above. In
particular, the simulations carried out for that case seem represen-
tative for the case with pancreatic cancer with sparse ECM with
input parameters for k̂w; Tv , and Tl as indicated in Table 4. Hence,
we focus on the case with dense ECM. The dense ECM is accounted
for by letting the resistance force through k̂w vary within a larger
interval and with higher values but such that it takes a constant
value for each in silico tumor. At the same time we assume that
Fig. 8. Increased aggressiveness, compartmentalized ECM. (A) Tumor cell volume fraction distribution now has several fingers migrating out from the primary tumor and
several isolated islands, as compared to the previous case seen in Fig. 7 (C). (B) Fibroblasts are migrating in groups towards the lymphatics, causing the fingering effect seen in
(A). (C) Chemokine concentration C is similar to the previous cases. (D) Transforming growth factor concentration H correlates to fibroblast concentration seen in (B). The
chemical distribution is heterogeneous and has positive gradients in the direction of the lymphatics.
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cular vessels giving rise to a lower value of Tv , as reflected by the
interval given in Table 4 (dense). This also ensures that the result-
ing IFP values remain within a pathological reasonable range. We
assume that the lymphatic network is characterized as before.
Again, an ensemble of 50 in silico pancreatic tumors are generated.
The corresponding IFP at the two different positions (ventral and
dorsal) are recorded and plotted in Fig. 9 (panel D). Analogous to
Fig. 2 the ventral IFP and dorsal IFP seen on the axes describe that
the measurements are performed at two different positions corre-
sponding to grid box 29;29ð Þ and grid box 33;33ð Þ on a grid of
61 61 grid blocks. Similar to the experimental results shown in
Fig. 9 (panel B), the resulting IFP shows a heterogeneous distribu-
tion. In the following, we take a closer look at possible mechanisms
behind this heterogeneous intratumoral IFP.
3.5.1. Dense ECM, high maximal IFP
We choose a member from the stochastic generated ensemble
different from the one used for homogeneous HL-16 cervical with
respect to Tv and Tl distribution as well as the initial fibroblast dis-
tribution. Then we simulate tumor progression for a time period of
T ¼ 50 (5.8 days). The results are shown in Fig. 10–12. Some essen-
tial points are:
 The heterogeneity in the microvascular network through Tv is
seen in Fig. 10 (panel A) as well as for Tl (panel B). The dense
ECM is reflected by a high value of k̂w around 12 as seen in
Fig. 9 (panel H). Corresponding to this characterization of14TME, the resulting IFP shown in Fig. 11 (panel A) is high (max-
imum around 35 mmHg) and heterogeneous within the tumor.
The dorsal and ventral IFP take the values 26 and 31,
respectively.
 The tumor cell migration behavior is seen in Fig. 11 (panel C)
and is largely a result of the fibroblast migration behavior seen
in panel D. The invasive front is fairly regular with no indication
of metastatic propensity. This is naturally linked to the rela-
tively homogeneous distribution of chemokine (panel E) and
TGF growth factor (panel F). However, we may allow the distri-
bution of the TGF factor H becoming more heterogeneous (as a
result of the heterogenous Tl) by modifying the values of the
rate coefficients represented by k2if g involved in the
transport-reaction equation for H in (1)8. We modify k2if g as
we did for the in silico cervical model. Fig. 12 (panel A) shows
how the cell-fibroblast interaction now results in formation of
many isolated islands, a behavior which is natural to link to
high metastatic propensity. This is a consequence of the hetero-
geneous distribution of TGF (panel D) and the resulting hetero-
geneous distribution of fibroblasts (panel B).
4. Discussion
4.1. Conclusions
The in silico cervical cancer model has demonstrated that
homogeneous and sparse ECM was associated with a relatively
constant (uniform) intratumoral IFP. This was observed despite
Fig. 9. Panc-1 pancreatic carcinoma. Experimental results for (i) sparse ECM (A, E); (ii) dense ECM (B,F). A, B IFP measurements taken at two different places within a tumor
for a total of 15 of each type of histology, corresponding to E and F. The respective coefficient of determination for A and B are R2 ¼ 0:96 and R2 ¼ 0:54. The computational
model uses 50 tumors of each type of histology to plot the two IFP measurements in C and D. Within each plot the R2 value is shown. The corresponding histology is
represented by k̂w in G and H. Panels (A), (B), (E) and (F) were reproduced from Hansem et al. (2019) [DOI: 10.1016/j.tranon.2019.05.012].
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Fig. 10. Parameters characterizing the vascular and lymphatic system, dense ECM: (A) The vascular filtration constant Tv that determines the fluid production from the
blood vessels within the tumor. (B) Tl characterizing the lymphatic network, which is placed in the area surrounding the primary tumor. The values of both Tv and Tl are
generated through a Gaussian variogram, while the placement of the vessels is constant.
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result of heterogeneous accumulation of solid stress owing to
tumor growth (Mpekris et al., 2015; Jain et al., 2014), was assumed
by generating Tv as a 2D Gaussian variogram and constrained such
that the resulting IFP varied in the relevant range 10–45 mmHg.
Inclusion of compartments separated with high-resistant bands
was associated with heterogeneous intratumoral IFP when the
heterogeneous Tv was generated similar to the case with homoge-
neous ECM structure. This confirms the underlying hypothesis sug-
gested in Hansem et al. (2019) that structures within the ECM that
prevent fluid flow can explain the heterogeneous IFP observed for
HL-16 cervical carcinoma.
For pancreatic cancer the in silico model demonstrated that
dense ECM structure (but homogeneous) combined with heteroge-
neous microvascular density through the randomly generated Tv
typically gave rise to a heterogeneous intratumoral IFP. The dense
ECM structure, as reflected by a high resistance force to fluid flow
through a uniform but high k̂w, implies that the heterogeneity in Tv
is translated into a heterogeneous IFP. In conclusion, the in silico
model confirms that tissue stromal elements represented a barrier
against interstitial convection, thus preventing local differences in
IFP from being leveled out by intratumoral fluid flow for the case
with Panc-1 pancreatic carcinoma (Hansem et al., 2019).
By varying the parameters k2if g that regulate the production/-
consumption of TGF, a more heterogeneous distribution was
achieved which gave rise to more aggressive behavior, both for
tumor cells and fibroblasts (Figs. 5, 8,12). These figures are
included in order to illustrate that the in silico model is able to
yield a variety of results depending on the set parameters. It is also
important to note, that this attribute of the model could be used in
the manner of tuning parameters to better comply with an individ-
ual tumor where more specific information is available (Hormuth
et al., 2019; Jarrett et al., 2018). For instance, in our simulations
we have assumed that the characteristics with regard to the cell-
substrate resistance force, cell–cell adhesion, chemotaxis coeffi-
cients and so on, are the same for both tumor types. While this is
a clean way of performing simulations, it is not necessarily true
and one could envision to use different sets of parameters for the
two tumors.
The proposed in silico model, previously explored and tested in
Urdal et al. (2019) and Waldeland et al. (2020), accounts for fluid-
sensitive migration mechanisms found fromin vitrostudies (Shieh
et al., 2011; Polacheck et al., 2011) which involve autologous
chemotaxis related to cancer cells and fibroblasts, combined with16ECM remodelling and cell-fibroblast interaction. The combination
of the leaky intratumoral vascular network and the peritumoral
lymphatic network which collects this fluid gives rise to elevated
IFP. This situation might be associated with high metastatic
propensity because hem- and lymphangiogenic factors, proteolytic
enzymes, cytokines, and other metastasis-promoting molecules
are transported from the primary tumor into peritumoral lymphat-
ics (Wiig and Swartz, 2012; Hansem et al., 2019). The in silico
model has demonstrated that when tumor cells are armed with
these mechanisms, the progression of the tumor can result in
aggressive behavior where groups of tumor cells detach from the
primary tumor and form isolated islands. It is natural to link this
behavior to increased metastatic propensity. In fact, the study in
Onozato et al. (2013), though in the context of lung cancer, found
a direct association between formation of isolated islands com-
posed of groups of tumor cells and metastatic propensity. The
prognosis of lung adenocarcinomas with tumor islands was signif-
icantly worse than those without. The in silico model suggests that
the combination of heterogeneous fibroblast migration and cell-
fibroblast interaction can be a driver for this aggressive behavior.
The findings in Hansem et al. (2019) have suggested that the com-
mon assumption that resistance to interstitial fluid flow is low in
tumor tissue is not necessarily valid for tumors developing a com-
plex, dense, and heterogeneous stroma. The suggested in silico
model has more precisely illustrated the mechanisms that most
likely are at play. In particular, it has demonstrated how barriers
against interstitial convection may have significant implications
for the distribution of all kinds soluble molecules produced and
secreted by cancer and stromal cells. This also will carry over to
the distribution of chemical therapeutic agents. The computer
model therefore can be interesting to use to explore barriers for
efficient delivery of therapeutic drugs.
4.2. Limitations of the model
A limitation of the current version of the in silico model is that it
does not explain the reported correlation that seems to exist
between high IFP and high metastatic propensity, as found in
Hansem et al. (2019), Andersen et al. (2017) and related work
Hompland et al. (2012). Presuming that isolated islands is a means
to metastasis, the model does not indicate that a tumor case with
high IFP tends to be more metastatic. Both high IFP tumors and low
IFP tumors show a similar tendency to generate isolated islands.
More precisely, this behavior seems to depend more strongly on
Fig. 11. Simulation results, dense ECM: (A) The resulting IFP is clearly correlated to the vascular filtration constant Tv shown in Fig. 10A. The resistance to fluid flow within
the tumor is high (high k̂w value), which causes the pressure not to be evened out, leading to heterogeneous IFP. (B) Interstitial fluid velocity is low for this type of histology,
even though it has a similar magnitude in IFP as for previous cases. This is caused by the high resistsance to fluid flow within the tumor, leading to a lower exit velocity of the
fluid. (C) The tumor cell volume fraction is fairly homogeneous and the invasion is quite limited. (D) Fibroblasts show little aggressive behavior and have not migrated far
from their initial position. (E) Due to the low fluid velocity, chemokine concentration in peritumoral region is higher than for the case with sparse ECM in Fig. 4. (F) TGF
distribution.
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the level of IFP. In fact, we found that the parameter family k2if g
in (1)8 which controls the production, consumption and decay of
TGF, largely affected the level of heterogenity in TGF distribution
in the peritumoral region. Apparently, the mathematical model
lacks some sort of aggressiveness when it comes to fluid-
sensitive migration mechanisms. However, it has been observed
(Waldeland and Evje, 2018; Evje and Waldeland, 2019) that math-
ematical models which include the combination of downstream
migration driven by autologous chemotaxis and strain-induced
upstream mechanisms (Follain et al., 2020; Polacheck et al.,
2011; Polacheck et al., 2014) suggest that aggressive tumor cell
behavior is correlated to higher IFP. An interesting extension of
the mathematical model discussed in the current work would be
to account for such mechanisms.
The multiphase model explored in this work has been designed
to capture bulk-level aspects of tumor growth and metastatic
propensity when constrained by data from the study of preclinical
models in Hansem et al. (2019). In that sense the model bears sim-17ilarities to the mathematical models explored in Weis et al. (2015)
and Weis et al. (2017) which focus on capturing first-order effects
pertaining to tumor progression and avoid representing many dif-
ferent parameters which are impractical or impossible to measure
clinically. Extended computer models may also involve a multi-
scale approach where one can explore tumor growth by consider-
ing major biological events at both tissue, cellular, and subcellular
scale (Rahman et al., 2017). This has been outside the scope of the
current investigations. Finally, in light of the works (Breward et al.,
2002; Byrne et al., 2003; Hubbard and Byrne, 2013; Wu et al.,
2013; Wu et al., 2014; Mascheroni et al., 2016; Mascheroni et al.,
2017; d’Esposito et al., 2018; Lewin et al., 2020; Mpekris et al.,
2015; Angeli and Stylianopoulos, 2016; Weis et al., 2015; Jarrett
et al., 2018; Hormuth et al., 2019) mentioned in the introduction,
there is certainly room for improvements of the current version
of the model by including other effects relevant for tumor progres-
sion that currently are ignored. However, such extensions might be
guided by a concrete need to use the model to explain certain
experimental findings.
Fig. 12. Increased aggressiveness, dense ECM. (A) The cancer cells now invade much further into the surrounding tissue, leading to both isolated islands and fingering. (B)
Fibroblasts migrate in small clusters outwards from the primary tumor, thereby guiding groups of cancer cells effectively away from the primary tumor. (C) The chemokine
concentration is heterogeneous in its concentration profile. (D) Transforming growth factor concentration H distribution is heterogeneous, causing fibroblasts to move in
clusters.
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Functions involved in cell migration given by Eqs. (6) and (7) (from Urdal et al.
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(df =10; cf =7.5 kPa)
KC Cð Þ =  KC11þexp nC CCMð Þð Þ (KC1=25 kPa; nC ¼ 8=C

3
Appendix A. Input parameters
See Tables 5–8.Table 5
Reference variables.
Variable Description Values
T Reference time 104 s
L Reference length 0:01 m
u Reference velocity 106 m=s
D Reference diffusion 108 m2=s
P Reference pressure 104 Pa
C;H Reference chemokine, TGF density 104 kg=m3
CM ;HM Max chemokine, TGF density 0:3C;0:5H
18Appendix B. Discretization of the model
We solve the model (1) subject to the boundary condition (9)
and the initial conditions (10). The main steps in the solution
approach are as follows: We assume that we have an approximate
solution at time level tn given by anc ;anf ;C
n;Hn
 
. Then, we want tom =kg)
KH Hð Þ =  KH11þexp nH HHMð Þð Þ (KH1=50 kPa;
nH ¼ 16=H m3=kg)
f̂ c ac ;af
  = ac af f̂cf þac f̂cf þf̂fð Þ½ 




f̂c f̂cfþf̂c f̂fþf̂cf f̂fð Þ
(see Eqs. (2) and (3))
f̂ f ac ;af
  = af ac f̂cf þaf f̂cfþf̂cð Þ½ 




f̂c f̂cfþf̂c f̂fþf̂cf f̂fð Þ
(see Eqs. (2) and (3))
ĥ1 ac ;af
  = aca2wf̂w ac f̂f þf̂cfð Þþaf f̂cf½ /




f̂c f̂cfþf̂c f̂fþf̂cf f̂fð Þ
(see Eqs. (2) and (3))
ĥ2 ac ;af
  = acaf acaf a2wf̂w f̂cf
 
/




f̂c f̂cfþf̂c f̂fþf̂cf f̂fð Þ
(see Eqs. (2) and (3))
ĥ3 ac ;af
  = af a2wf̂w ac f̂cf þaf f̂cþf̂cfð Þ½ /




f̂c f̂cfþf̂c f̂fþf̂cf f̂fð Þ
(see Eqs. (2) and (3))
Table 7
Parameters characterizing the mobility of tumor cells and fibroblasts by Eq. (2) (from
Urdal et al. (2019)).
Variable Description Values
Iw; k̂w; rw fluid-ECM interaction 2  1012 (Pas=m2)(*), 1, 0
Ic ; rc cell-ECM interaction 2000Iw (Pas=m2), 0.6
If ; k̂f ; rf fibroblast-ECM
interaction
100Iw (Pas=m2), 1, 0.6
Icf ; rcf ; rfc cell-fibroblast
interaction
1000Iw (Pas=m2), 0.5, 0.5
A;B (k̂c) Reduced cell-ECM
resistance (see Eq. (3))
0.7, 50
(*) I1w hydraulic conductivity
reference
5  1013 (m2=Pas)
= 6:7  107 cm2=mmHgs 
Table 8
Parameters for production/decay of chemical agents by Eqs. (1)7,8 (from Urdal et al.
(2019))
Variable Description Values
DC Diffusion coefficient chemokine 14 1012 m2=s
DH Diffusion coefficient TGF 8 1012 m2=s
k11 Proteolytically freed chemokine 5 103 m3=kgs
k12 Logistic rate constant chemokine 5 103 m3=kgs
k13 Cell consumption rate chemokine 1 104 1=s
mC ;MC Logistic rate exponent, absorption percentage 0:25;50%
k21 Proteolytically freed TGF 1:4 106
m3=kgs
k22 Logistic rate constant TGF 4 106 m3=kgs
k23 Logistic rate constant TGF 5:5 107
m3=kgs
k24 Cell consumption rate TGF 4 103 1=s
k25 Natural decay of TGF 2 105 1=s
mH ;MH Logistic rate exponent, absorption percentage 0:2;50%






new time step tnþ1:
(i) First, we solve the elliptic, steady-state diffusion problem for
the IF pressure Pnw:r k̂TrPw
 
;¼Tv ePv  Pw þ Tl Pw  ePl 
r  k̂cr DPcw þKCð Þ
 




(ii) Then we can compute the corresponding total velocity UnT
from





where Ui ¼ aiui; i ¼ w; c; f . Hence, we have the information we need
to evaulate unc ;u
n
f , and u
n
w based on (6)–(8).
(iii) Armed with interstitial velocities unc and u
n
f at time level t
n,
we can compute updated volume fractions anþ1c and a
nþ1
f from
(1)1,2. Moreover, by means of unw we can compute updated con-
centrations Cnþ1 and Hnþ1 from (1)7,8. We employ standard
upwind for spatial discretization of convective terms (explicit
in time) whereas diffusion terms are treated implicitly in time.19References
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